About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a Healthcare company based in United States founded in 1964. Developer of blood collection, therapeutic apheresis, and cell collection products. Its chief executive, as recorded, is Antoinette Gawin. Its website terumobct.com draws about 57 thousand monthly visits. Terumo Blood and Cell Technologies offers products and services including Trima Accel Automated Blood Collection System and Spectra Optia Apheresis System. Its focus areas include Traditional Medical Devices. Its legal entity is Terumo BCT, Inc.
Company details
Founded in 1964 and headquartered in the United States, Terumo Blood and Cell Technologies operates in the medical device sector, focusing on blood processing and bioprocessing solutions. Automated systems for blood collection, therapeutic apheresis platforms like Spectra Optia, and centrifugal technologies such as COBE are provided. Cell expansion, separation tools, and bioprocessing equipment support clinical and research applications across global markets.
- Headquarters United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website terumobct.com
- Social LinkedIn X Facebook YouTube
- Legal Name Terumo Bct, Inc
- Latest Funding Round$1.9M (USD), Grant
Jul 2016
- InvestorsEuropean Union
& 3 more
Products & Services of Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies offers a comprehensive portfolio of products and services, including Trima Accel Automated Blood Collection System and Spectra Optia Apheresis System.
Automated blood collection is facilitated for safe processing and component separation.
Therapeutic procedures such as plasma exchange are performed to treat patients with various diseases.
Apps and channels of Terumo Blood and Cell Technologies
its YouTube channel Terumo Blood and Cell Technologies has 1.9K subscribers and 30 videos.
Videos from Terumo Blood and Cell Technologies
The most watched videos on Terumo Blood and Cell Technologies's YouTube channel, Terumo Blood and Cell Technologies (1.9K subscribers). Click a video to play it here.
More on Terumo Blood and Cell Technologies.
Funding Insights of Terumo Blood and Cell Technologies
- Total Rounds 6
- Last Round Grant — $1.9M
- First Round $5.02M
(Sep 2008)
- Investors Count 4
All 6 funding rounds of Terumo Blood and Cell Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2016 | $1.9M | Grant | – | – | |
| Jun 2016 | $17.4M | Grant | – | – | |
| May 2015 | $671,791 | Grant | – | – | |
| Jan 2015 | $280,556 | Grant | – | – | |
| Aug 2009 | $5.64M | Grant | – | – | |
| Sep 2008 | $5.02M | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include European Union, USAGov and Public Health Emergency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entity focused on information and services | 2000 | usa.gov | United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| phe.gov | ||||
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States |
Investor details for Terumo Blood and Cell Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Terumo Blood and Cell Technologies
315 people are tracked at Terumo Blood and Cell Technologies (71 in leadership, 244 in team).
| Name | Role | Group |
|---|---|---|
Antoinette Gawin | CEO & President | Leadership |
Rusty Spinney | EVP & CFO | Leadership |
Sylvain Lacomble | Vice President - EMEA (europe, Middle East And Africa) | Leadership |
Heather Welty | Director Of Product Lifecycle Excellence | Leadership |
Jim Holmes | Vp, Product Engineering And System Integration | Leadership |
Derek Kronberg | Vice President, Global Process Engineering | Leadership |
Joris Diels | Commercial Director, Global CMO Solutions Lead | Leadership |
Marcela Villamar | Director Global Total Rewards & HRIS | Leadership |
Arti Shadid | Sr. Director, Global Sourcing & Supply Strategy | Leadership |
Khoi le | Director Of R&d, Global Software Development | Leadership |
Rita Hermann | Director Of Digital Transformation, Chief Of Staff | Leadership |
Philly Winterowd | Director Of Financial Planning And Analysis | Leadership |
Shaireen Khawaja | Program Director Global Operations | Leadership |
Oscar Rodriguez | Director, Global Process Engineering | Leadership |
Joseph Konrad | Director, Global Supplier Quality Engineering | Leadership |
Rachael Castroverde | Vice President Of Global Services | Leadership |
Michelle Marks | Interim General Manager - Plasma Innovations | Leadership |
Victor Turpaud | Director, Commercialization Enablement | Leadership |
Elena Lim | SEA General Manager | Leadership |
Janet Johnson | VP, Global Regulatory Affairs & Labeling | Leadership |
295 more people are available in the full profile.
Complete people profiles for Terumo Blood and Cell Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Terumo Blood and Cell Technologies
3 dated milestones of Terumo Blood and Cell Technologies across 52 years, from founding to its latest funding, stage changes and deals.
- Founded Terumo Blood and Cell Technologies is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Grant, of $1.9M.
Web traffic of Terumo Blood and Cell Technologies
The website of Terumo Blood and Cell Technologies (terumobct.com) receives about 56.6K visits a month.
- Monthly visits56.6K
▲ 39.1% vs previous month
Websites whose visitors overlap most with Terumo Blood and Cell Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| terumomedical.com | 100% | 14.7K | #1,709,290 | View details | |
| terumo.com | 98% | 83.8K | #425,995 | View details | |
| haemonetics.com | 86% | 50.5K | #632,767 | View details | |
| genesisbps.com | 73% | #9,003,943 | View details | ||
terumo-us.com | terumo-us.com | 71% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Terumo Blood and Cell Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Terumo Blood and Cell Technologies (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Terumo Blood And Cell Technologies
Complete news archive for Terumo Blood and Cell Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies was founded in 1964 and raised its 1st funding round 44 years after it was founded.
Terumo Blood and Cell Technologies is headquartered in United States.
Antoinette Gawin is the CEO of Terumo Blood and Cell Technologies, as recorded in our data.
Founded in 1964 and headquartered in the United States, Terumo Blood and Cell Technologies operates in the medical device sector, focusing on blood processing and bioprocessing solutions. Automated systems for blood collection, therapeutic apheresis platforms like Spectra Optia, and centrifugal technologies such as COBE are provided. Cell expansion, separation tools, and bioprocessing equipment support clinical and research applications across global markets.
Terumo Blood and Cell Technologies offers Trima Accel Automated Blood Collection System and Spectra Optia Apheresis System.
Terumo Blood and Cell Technologies has 4 investors. Key investors include European Union, USAGov, Public Health Emergency, and Military Health.
Terumo Blood and Cell Technologies operates through Terumo Bct, Inc.